WikiWealth

Home > SWOT Analysis > Medarex (MEDX) SWOT Analysis

Strengths

Weaknesses

Opportunities

Threats

Medarex (MEDX) SWOT Analysis Profile

Medarex, Inc., founded in 1987, is a biopharmaceutical company that researches and develops human antibody-based therapeutic products to treat cancer, inflammation, autoimmune disorders, and other life-threatening and debilitating diseases. Headquartered in Princeton, New Jersey, Medarex, Inc. collaborates with a number of major drug companies including Amgen, Inc., Eli Lilly and Company, and Bristol-Myers Squibb Company. (read full profile)

Additional Information

What is a SWOT Analysis? It is a way of evaluating the strengths, weaknesses, opportunities, and threats that affect something. See WikiWealth's SWOT tutorial for help. Remember, vote up the most important comments. Check out WikiWealth's entire database of free SWOT reports or use our SWOT analysis generator to create your own SWOT template.

Receive News & Ratings Via Email